References
Genomic Health, Inc. 2008. "What is Oncotype DX?" Available at http://www.genomichealth.com Accessed April 2008.
"What is breast cancer?" The American Cancer Society. September 2007. http://www.cancer.org. Accessed March 2008.
"How many women get breast cancer?" The American Cancer Society. September 26, 2007. http://www.cancer.org. Accessed March 2008.
"How is breast cancer staged?" The American Cancer Society. September 2007. http://www.cancer.org. Accessed March 2008.
"Abortion, miscarriage, and breast cancer risk." The National Cancer Institute. http://www.cancer.gov. Accessed March 2008.
Ries LAG, Harkins D, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2003. Bethesda, MD: National Cancer Institute; 2006.
Vogel VG. Management of the high-risk patient. Surg Clin North Am. 2003;83(4):733-751.
"ACS Advises MRIs for Some at High Risk of Breast Cancer." The American Cancer Society. March 28, 2007. Accessed March 28, 2007.
"FDA approves Tykerb for advanced breast cancer patients." The U.S. Food and Drug Administration. 2007. http://www.fda.gov
San Antonio Breast Cancer Symposium, Dec. 14-17, 2006. Donald Berry, PhD, department of biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston. Peter Ravdin, MD, PhD, department of biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston. Eric Winer, MD, Dana-Farber Cancer Institute, Boston.
"Detailed Guide: Breast Cancer—What are the Key Statistics for Breast Cancer?" American Cancer Society copyright 2007. http://www.cancer.org. Accessed February 2007.
"Breast self-exams: One way to detect breast cancer." Mayo Clinic. July 1, 2005. http://www.mayoclinic.com. Accessed September 15, 2005.
"Mammograms." Womenshealth.gov. National Women's Health Information Center. US Department of Health and Human Services. Office on Women's Health. March 2002. http://www.4women.gov. Accessed September 15, 2005.
"Sentinel Node Biopsy." National Cancer Institute. http://www.nci.nih.gov.
U. Veronesi, et al. "Sentinel Node Biopsy May Be as Good as Regular Lymph Node Biopsy," New England Journal of Medicine, August 7, 2003; last updated Sept. 2003.http://www.breastcancer.org. Accessed March 2004
"Prophylactic Mastectomy." Last updated February 2004. http://www.breastcancer.org. Accessed March 2004
"Bone Marrow Or Stem Cell Transplant Helps Reduce Breast Cancer Relapses," 1999. American Society of Clinical Oncology Conference, Atlanta, Georgia.
"Breast Cancer." CancerNet. National Cancer Institute. National Institutes of Health. http://www.cancer.gov. Accessed November 2003.
Canadian Medical Association Journal 2001;164:1837-1846,1851-1852.
"20-Year Follow-up of a Trial Comparing Total Mastectomy with Lumpectomy" New England Journal of Medicine, This Week in the Journal. October 2002. http://content.nejm.org. Accessed November 2002.
"The Facts for Life." The Komen Foundation. http://www.komen.org. Accessed November 2003.
"Updated Breast Cancer Screening Guidelines Released" American Cancer Society, May 15, 2003. http://www.cancer.org. Accessed November 2003.
Breast Cancer: Detailed Guide. American Cancer Society. 2003. http://www.cancer.org. Accessed May 2003.
"Cancer Facts and Figures 2003" American Cancer Society. http://www.cancer.org. Accessed May 2003.
King MC, et al. "Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2." Science. 2003;302(5645):643-646. http://www.sciencemag.org. Accessed November 2003.
Gross PE, et al. "A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer" New England Journal of Medicine. 2003;340:1793-1802. http://content.nejm.org. Accessed November 2003.
"Summary from the General and Plastic Surgery Devices Panel Meeting—October 14 and 15, 2003." US Food and Drug Aministration. Center for Devices and Radiological Health. October 2003. http://www.fda.gov. Accessed November 2003.
Coombes R, Hall E, Gibson L, et al. A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. N Engl J Med. 2004;350:1081-1092.
Howell A, Cuzick J, Baum M, et al. ATAC Trialists' Group. Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet. 2005;365(9453):60-2.
"General information about breast cancer." The National Cancer Institute. June 22, 2005. http://www.cancer.gov. Accessed January 2006.
Piccart-Gebhart MJ, Procter M, Leyland-Jones B et al. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med. 2005;353(16):1659-72.
Romond E. H., Perez E. A., Bryant J, et al. Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer. N Engl J Med 2005; 353:1673-1684, Oct 20, 2005
"Study of Tamoxifen and Raloxifine (STAR) Trial." The National Cancer Institute. Updated 4/26/06. http://www.cancer.gov. Accessed April 26, 2006.
"What are the risk factors for breast cancer?" American Cancer Society. September 2006. http://www.cancer.org. Accessed February 2007.
"What is breast cancer?" American Cancer Society. September 2006. http://www.cancer.org. Accessed February 2007.
| |
|
View References for this Health Topic
|
Create Date: 2/1/02
Date Last Updated: 4/21/08
Review Date: 4/18/08
|
|
